jCell Therapy | Retinitis Pigmentosa | Degenerative Retinal Disorders | jCyte Inc.
EU Regulatory Pathways for ATMPs: Standard, Accelerated and Adaptive Pathways to Marketing Authorisation - ScienceDirect
Powered by CIRM Grant, jCyte Launches New Clinical Trial for RP - Global Genes
jCyte starts second phase of stem cell clinical trial targeting vision loss | The Stem Cellar
Targeting human retinal progenitor cell injections for retinitis pigmentosa
JCyte signs ex-US licensing deal with Santen for retinal disease therapy
JCyte Licenses Ex-US Rights to Retinitis Pigmentosa Cell Therapy to Santen for $252 Million - Global Genes
jCyte starts second phase of stem cell clinical trial targeting vision loss | The Stem Cellar
Rebecca Kammer - Vice President of Clinical Operations - jCyte, Inc. | LinkedIn
Phase 2b Clinical Study of Safety and Efficacy of Intravitreal Injection of Retinal Progenitor Cells (jCell) for Treatment of Retinitis Pigmentosa | California's Stem Cell Agency
Stem/progenitor cell-based transplantation for retinal degeneration: a review of clinical trials | Cell Death & Disease
Stem cell therapy for retinitis pigmentosa found safe, well-tolerated in first-stage clinical trial | UCI News | UCI
UCI clinical trial targeting retinitis pigmentosa receives $6.6M grant from California Institute for Regenerative Medicine | School of Medicine | University of California, Irvine
jCyte Shares Encouraging Update on Clinical Trial for Retinitis Pigmentosa | The Stem Cellar
National Science Call - 12/4/2019 — Foundation Fighting Blindness
Retina Global - Retinitis pigmentosa patients with a baseline central visual field diameter greater than 20 degrees had a profound response to jCell treatment in #jCyte, Inc.'s Phase 2b study, the largest
Santen Pharmaceutical and jCyte Enter Agreement for jCell Therapy for Retinitis Pigmentosa | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists
Retinitis Pigmentosa Archives - Global Genes
Stem/progenitor cell-based transplantation for retinal degeneration: a review of clinical trials | Cell Death & Disease
jCyte Inc. Announces Promising Results In Retinitis Pigmentosa | The Optical Journal
jCell Therapy | Retinitis Pigmentosa | Degenerative Retinal Disorders | jCyte Inc.
Comet Creative - jCyte's new website gave the company further credibility to raise capital for a clinical trial. The straight-forward content easily translates the complexity of the firm's retinitis pigmentosa drug research
